SWOG clinical trial number
SWOG-8243

Evaluation of VM-26 and Ifosfamide in Refractory Adult Acute Lymphocytic Leukemia

Closed
Phase
Published
Abbreviated Title
Evaluation of VM-26 and Ifosfamide in Refractory Adult Acute Lymphocytic Leukemia
Activated
02/18/1983
Closed
03/20/1986

Publication Information Expand/Collapse

1987

Phase II evaluation of teniposide and ifosfamide in refractoryadult acute lymphocytic leukemia: A Southwest Oncology Group study.

DH Ryan;KJ Kopecky;D Head;CN Gumbart;MR Grever;C Karanes;JK Weick;C Coltman, Jr Cancer Treat Rep 71(7-8):713-716

Southwest Oncology Group (SWOG) trial: VM-26 and ifosfamide (IF)in refractory adult lymphocytic leukemia (ALL).

DH Ryan;KJ Kopecky;CH Gumbart;JN Bickers ASCO :#C-561

1985

Phase II of VM-26 and ifosfamide in refractory adult acute lymphocytic leukemia (ALL). A Southwest Oncology Group study.

D Ryan;J Bickers;J Athens;C Coltman, Jr ASCO, #C-599

1984

VM-26 and ifosfamide in refractory adult acute lymphocytic leukemia

D Ryan ASCO #C-599